Cargando…

Influence of Prednisone on Inflammatory Biomarkers in Community‐Acquired Pneumonia: Secondary Analysis of a Randomized Trial

Glucocorticoids are frequently prescribed in inflammatory diseases and have recently experienced a boom in the treatment of COVID‐19. Small studies have shown an effect of glucocorticoids on inflammatory marker levels, but definitive proof is lacking. We investigated the influence of prednisone on i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raess, Natalie, Schuetz, Philipp, Cesana‐Nigro, Nicole, Winzeler, Bettina, Urwyler, Sandrine A., Schaedelin, Sabine, Rodondi, Nicolas, Blum, Manuel R., Briel, Matthias, Mueller, Beat, Christ‐Crain, Mirjam, Blum, Claudine A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Editor's Choice: Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242868/ https://www.ncbi.nlm.nih.gov/pubmed/34031890 http://dx.doi.org/10.1002/jcph.1914

Ejemplares similares

Adjunct prednisone therapy for patients with community-acquired pneumonia: a randomized, placebo-controlled multicenter trial
por: Blum, CA, et al.
Publicado: (2015)

Corticosteroid treatment for community-acquired pneumonia - the STEP trial: study protocol for a randomized controlled trial
por: Blum, Claudine A, et al.
Publicado: (2014)

Association of Adrenal Function and Disease Severity in Community-Acquired Pneumonia
por: Mueller, Cornelia, et al.
Publicado: (2014)

Copeptin levels and commonly used laboratory parameters in hospitalised patients with severe hypernatraemia - the “Co-MED study”
por: Nigro, Nicole, et al.
Publicado: (2018)

Prognostic Value of Dehydroepiandrosterone-Sulfate and Other Parameters of Adrenal Function in Acute Ischemic Stroke
por: Blum, Claudine A., et al.
Publicado: (2013)

The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
por: Atila, Cihan, et al.
Publicado: (2022)

SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019)

Copeptin is not useful as a marker of malignant disease in the syndrome of inappropriate antidiuresis
por: Winzeler, Bettina, et al.
Publicado: (2019)

No obesity paradox in patients with community-acquired pneumonia – secondary analysis of a randomized controlled trial
por: Borisov, Angel N., et al.
Publicado: (2022)

Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome
por: Ebrahimi, Fahim, et al.
Publicado: (2021)

Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial
por: Ebrahimi, Fahim, et al.
Publicado: (2019)

Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study
por: Blum, Claudine Angela, et al.
Publicado: (2017)

Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients
por: Kutz, Alexander, et al.
Publicado: (2014)

Copeptin Levels Remain Unchanged during the Menstrual Cycle
por: Blum, Claudine A., et al.
Publicado: (2014)

Infection biomarkers in primary care patients with acute respiratory tract infections–comparison of Procalcitonin and C-reactive protein
por: Meili, Marc, et al.
Publicado: (2016)

Predictors for length of hospital stay in patients with community-acquired Pneumonia: Results from a Swiss Multicenter study
por: Suter-Widmer, Isabelle, et al.
Publicado: (2012)

GLP1 Receptor Agonists Reduce Fluid Intake in Primary Polydipsia
por: Winzeler, Bettina Felicitas, et al.
Publicado: (2021)

BNP but Not s-cTnln Is Associated with Cardioembolic Aetiology and Predicts Short and Long Term Prognosis after Cerebrovascular Events
por: Nigro, Nicole, et al.
Publicado: (2014)

Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
por: Schuetz, Philipp, et al.
Publicado: (2010)

Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis
por: Refardt, Julie, et al.
Publicado: (2019)

Approach to the Patient: “Utility of the Copeptin Assay”
por: Christ-Crain, Mirjam, et al.
Publicado: (2022)

Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia
por: Schuetz, Philipp, et al.
Publicado: (2008)

Risk–benefit and cost–benefit ratio in headache treatment
por: Pini, L. A., et al.
Publicado: (2005)

Vedolizumab Immunogenicity With Long‐Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease
por: Wyant, Timothy, et al.
Publicado: (2021)

Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study
por: Odermatt, Jonas, et al.
Publicado: (2017)

Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]
por: Briel, Matthias, et al.
Publicado: (2005)

The National Early Warning Score (NEWS) for outcome prediction in emergency department patients with community-acquired pneumonia: results from a 6-year prospective cohort study
por: Sbiti-Rohr, Diana, et al.
Publicado: (2016)

Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department
por: Fiumefreddo, Rico, et al.
Publicado: (2009)

Hyponatremia and anti-diuretic hormone in Legionnaires’ disease
por: Schuetz, Philipp, et al.
Publicado: (2013)

RF25 | PMON179 Role of Apparent Strong Ion Difference in the Differential Diagnosis of Thiazide Associated Hyponatremia
por: Monnerat, Sophie, et al.
Publicado: (2022)

The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome
por: Popovic, Milica, et al.
Publicado: (2020)

Association of adrenal insufficiency with patient-oriented health-care outcomes in adult medical inpatients
por: Ebrahimi, Fahim, et al.
Publicado: (2019)

Empagliflozin Increases Short-Term Urinary Volume Output in Artificially Induced Syndrome of Inappropriate Antidiuresis
por: Refardt, Julie, et al.
Publicado: (2017)

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia
por: Müller, Beat, et al.
Publicado: (2007)

Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study
por: Nickler, Manuela, et al.
Publicado: (2017)

Impaired neural stem cell expansion and hypersensitivity to epileptic seizures in mice lacking the EGFR in the brain
por: Robson, Jonathan P., et al.
Publicado: (2018)

Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia
por: Christ-Crain, Mirjam, et al.
Publicado: (2010)

Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia
por: Baumgartner, Thomas, et al.
Publicado: (2018)

RAF dimers control vascular permeability and cytoskeletal rearrangements at endothelial cell‐cell junctions
por: Dorard, Coralie, et al.
Publicado: (2019)

Dihydrotestosterone is a predictor for mortality in males with community-acquired pneumonia: results of a 6-year follow-up study
por: Zurfluh, Seline, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a7m5jiu0jkf8fno8or75krj2iq